Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma - Muselaers, CHJ; Boers-Sonderen, MJ; Van Oostenbrugge, TJ (Eur Urol, 2016)